Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Afatinib × Clear all

Status

Completed 16 Terminated 2 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Glioblastoma 1 Fanconi Anemia 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1

Interventions

pembrolizumab 31 Blood Specimen Collection 29 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Cisplatin 11 atezolizumab 10 Drug Therapy 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Pemetrexed 8 Fluorouracil 8 olaparib 7 Trastuzumab 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 pertuzumab 6 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡